Arcadia Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,000
| Closed | -$222K | – | 261 |
|
|
2025
Q2 | $222K | Hold |
2,000
| – | – | 0.04% | 115 |
|
|
2025
Q1 | $224K | Hold |
2,000
| – | – | 0.04% | 116 |
|
|
2024
Q4 | $185K | Hold |
2,000
| – | – | 0.03% | 122 |
|
|
2024
Q3 | $168K | Hold |
2,000
| – | – | 0.03% | 132 |
|
|
2024
Q2 | $137K | Hold |
2,000
| – | – | 0.02% | 139 |
|
|
2024
Q1 | $147K | Hold |
2,000
| – | – | 0.03% | 137 |
|
|
2023
Q4 | $162K | Hold |
2,000
| – | – | 0.03% | 139 |
|
|
2023
Q3 | $150K | Hold |
2,000
| – | – | 0.03% | 137 |
|
|
2023
Q2 | $154K | Sell |
2,000
-355
| -15% | -$28.3K | 0.03% | 141 |
|
|
2023
Q1 | $195K | Hold |
2,355
| – | – | 0.04% | 133 |
|
|
2022
Q4 | $202K | Hold |
2,355
| – | – | 0.05% | 128 |
|
|
2022
Q3 | $145K | Hold |
2,355
| – | – | 0.04% | 135 |
|
|
2022
Q2 | $146K | Hold |
2,355
| – | – | 0.03% | 141 |
|
|
2022
Q1 | $140K | Hold |
2,355
| – | – | 0.03% | 150 |
|
|
2021
Q4 | $171K | Hold |
2,355
| – | – | 0.03% | 148 |
|
|
2021
Q3 | $164K | Hold |
2,355
| – | – | 0.03% | 146 |
|
|
2021
Q2 | $162K | Hold |
2,355
| – | – | 0.03% | 148 |
|
|
2021
Q1 | $152K | Hold |
2,355
| – | – | 0.03% | 144 |
|
|
2020
Q4 | $137K | Hold |
2,355
| – | – | 0.03% | 129 |
|
|
2020
Q3 | $149K | Buy |
+2,355
| New | +$163K | 0.03% | 129 |
|
|
2018
Q2 | – | Sell |
-1,100
| Closed | -$83K | – | 336 |
|
|
2018
Q1 | $83K | Hold |
1,100
| – | – | 0.02% | 179 |
|
|
2017
Q4 | $79K | Hold |
1,100
| – | – | 0.02% | 185 |
|
|
2017
Q3 | $89K | Hold |
1,100
| – | – | 0.03% | 171 |
|
|
2017
Q2 | $78K | Sell |
1,100
-5,500
| -83% | -$366K | 0.02% | 181 |
|
|
2017
Q1 | $448K | Sell |
6,600
-800
| -11% | -$56.3K | 0.14% | 97 |
|
|
2016
Q4 | $530K | Sell |
7,400
-7,833
| -51% | -$582K | 0.17% | 88 |
|
|
2016
Q3 | $1.21M | Sell |
15,233
-13
| -0.1% | -$1.06K | 0.4% | 67 |
|
|
2016
Q2 | $1.27M | Buy |
15,246
+146
| +1% | +$13K | 0.41% | 64 |
|
|
2016
Q1 | $1.39M | Sell |
15,100
-4,000
| -21% | -$361K | 0.46% | 64 |
|
|
2015
Q4 | $1.93M | Sell |
19,100
-5,800
| -23% | -$604K | 0.59% | 58 |
|
|
2015
Q3 | $2.44M | Sell |
24,900
-800
| -3% | -$88.8K | 0.75% | 55 |
|
|
2015
Q2 | $3.01M | Hold |
25,700
| – | – | 0.78% | 50 |
|
|
2015
Q1 | $2.52M | Sell |
25,700
-2,900
| -10% | -$294K | 0.71% | 55 |
|
|
2014
Q4 | $2.7M | Sell |
28,600
-8,600
| -23% | -$889K | 0.76% | 53 |
|
|
2014
Q3 | $3.96M | Hold |
37,200
| – | – | 1.19% | 37 |
|
|
2014
Q2 | $3.08M | Sell |
37,200
-11,800
| -24% | -$918K | 0.9% | 46 |
|
|
2014
Q1 | $3.47M | Sell |
49,000
-24,600
| -33% | -$1.93M | 1.01% | 42 |
|
|
2013
Q4 | $5.53M | Hold |
73,600
| – | – | 1.31% | 32 |
|
|
2013
Q3 | $4.63M | Hold |
73,600
| – | – | 1.21% | 36 |
|
|
2013
Q2 | $3.77M | Buy |
+73,600
| New | +$3.84M | 1.07% | 41 |
|
Other funds holding GILD
Arcadia Investment Management's GILD Position: Q3 2025 in Review
Arcadia Investment Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 2,000 shares — an estimated $222K sold.
Arcadia Investment Management first reported a position in GILD in Q2 2013 and held it in 40 quarters. The position peaked at $5.53M in Q4 2013. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Arcadia Investment Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Arcadia Investment Management sold 2,000 Gilead Sciences shares in Q3 2025, an estimated $222K.
- Arcadia Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 40 quarters.
- Arcadia Investment Management's Gilead Sciences position peaked at $5.53M in Q4 2013.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Arcadia Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.